Given the fact that biomarkers of tissue damage such as LDH, AST, ALT, and ferritin were increased in severely ill or deceased COVID-19 patients (Table 1 and references [5, 6]), increased percentages of hyperuricemia in COVID-19 patients, especially in deceased patients, may be a result of tissue damage/cell death. This evidence concerns the gene GPT and COVID-19.